Kevin S. Orwig

Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8–13) analogues containing non-natural arginine and lysine residues

M. Kyle Hadden, Kevin S. Orwig, Kyle P. Kokko et al. · Neuropharmacology · 2005 · 40 citations

Medicine, Medicinal Chemistry, Pharmacology +11

In Vitro Analysis of Stable, Receptor-Selective Neurotensin[8−13] Analogues

Kyle P. Kokko, M. Kyle Hadden, Kevin S. Orwig et al. · Journal of Medicinal Chemistry · 2003 · 40 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Comparison of N-Terminal Modifications on Neurotensin(8−13) Analogues Correlates Peptide Stability but Not Binding Affinity with in Vivo Efficacy

Kevin S. Orwig, McKensie R. Lassetter, M. Kyle Hadden et al. · Journal of Medicinal Chemistry · 2009 · 40 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

In vivo behavioral effects of stable, receptor-selective neurotensin[8?13] analogues that cross the blood?brain barrier

Kyle P. Kokko, M. Kyle Hadden, Karen M. Price et al. · Neuropharmacology · 2005 · 27 citations

Life Sciences, Neuroscience, Pharmacology +16

Synthesis of Ethylene-Bridged (N<i>^δ</i> to N<i>^ω</i>) Analogues of Arginine

Lundquist, Kevin S. Orwig, Thomas A. Dix · The Journal of Organic Chemistry · 1999 · 17 citations

Pharmacy, Chemistry, Medicinal Chemistry +6